Dohj LLC Has $498,000 Position in Align Technology, Inc. (NASDAQ:ALGN)

Dohj LLC reduced its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 5.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,518 shares of the medical equipment provider’s stock after selling 93 shares during the period. Dohj LLC’s holdings in Align Technology were worth $498,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of ALGN. Mather Group LLC. acquired a new position in Align Technology in the first quarter valued at approximately $26,000. Orion Capital Management LLC acquired a new stake in Align Technology in the third quarter worth $61,000. Valley National Advisers Inc. raised its holdings in Align Technology by 29.7% in the third quarter. Valley National Advisers Inc. now owns 214 shares of the medical equipment provider’s stock worth $65,000 after purchasing an additional 49 shares during the period. Venturi Wealth Management LLC raised its holdings in Align Technology by 97.2% in the fourth quarter. Venturi Wealth Management LLC now owns 280 shares of the medical equipment provider’s stock worth $77,000 after purchasing an additional 138 shares during the period. Finally, Scarborough Advisors LLC acquired a new stake in Align Technology in the fourth quarter worth $86,000. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Stock Performance

Shares of ALGN stock traded down $0.61 during midday trading on Thursday, hitting $243.00. 680,440 shares of the company were exchanged, compared to its average volume of 768,756. The firm has a market capitalization of $18.29 billion, a P/E ratio of 40.00, a PEG ratio of 4.35 and a beta of 1.62. The firm’s 50 day moving average price is $269.00 and its two-hundred day moving average price is $283.36. Align Technology, Inc. has a 52 week low of $176.34 and a 52 week high of $413.20.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, April 24th. The medical equipment provider reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.08. Align Technology had a net margin of 11.80% and a return on equity of 14.15%. The firm had revenue of $997.43 million for the quarter, compared to analyst estimates of $971.97 million. Analysts expect that Align Technology, Inc. will post 7.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Morgan Stanley increased their target price on shares of Align Technology from $344.00 to $360.00 and gave the stock an “overweight” rating in a report on Thursday, April 25th. Robert W. Baird raised their price objective on shares of Align Technology from $333.00 to $370.00 and gave the stock an “outperform” rating in a report on Thursday, April 25th. Evercore ISI dropped their price objective on shares of Align Technology from $370.00 to $300.00 and set an “outperform” rating on the stock in a report on Monday, June 10th. Stifel Nicolaus raised their price objective on shares of Align Technology from $350.00 to $400.00 and gave the stock a “buy” rating in a report on Thursday, April 18th. Finally, Piper Sandler dropped their price objective on shares of Align Technology from $375.00 to $330.00 and set an “overweight” rating on the stock in a report on Friday, June 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $346.50.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.